Guaifenesin Tablet, Extended Release
Product Images NDC 41415-997

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin (NDC 41415-997). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Publix Super Markets, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Principal Display Panel (1200 mg Extended-Release Tablet Blister Pack Carton)

Principal Display Panel (1200 mg Extended-Release Tablet Blister Pack Carton)
This is a description for a medication called Mucusrelief. It is an expectorant and contains 1200 mg of Guaifenesin. It aims to help loosen phlegm and bronchial secretions which can rid the bronchial passageways of mucus and make coughs more productive. The medication is available as extended-release tablets in a dose of 1 tablet every 12 hours. It should not be taken by children under 12 years old. The product can relieve chest congestion and compare to the active ingredient of Mucinex Maximum Strength. There is a warning that if the cough lasts for more than 7 days, comes back, or is accompanied by fever, rash, or persistent headache, the user should see a doctor as these could be signs of a serious illness.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.